2609 — Bayzed Health Cashflow Statement
0.000.00%
Last trade - 00:00- HK$8.12bn
- HK$8.69bn
- CNY1.19bn
Annual cashflow statement for Bayzed Health, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS |
| Standards: | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final |
| Net Income/Starting Line | -62.5 | -4.61 | 13.3 |
| Depreciation | |||
| Non-Cash Items | 24 | 27.5 | 22.3 |
| Unusual Items | |||
| Other Non-Cash Items | |||
| Changes in Working Capital | 78.4 | 19.2 | 45.5 |
| Change in Accounts Receivable | |||
| Change in Inventories | |||
| Change in Other Assets | |||
| Change in Accounts Payable | |||
| Change in Other Liabilities | |||
| Other Operating Cash Flow | |||
| Cash from Operating Activities | 114 | 128 | 169 |
| Capital Expenditures | -36.4 | -53.8 | -46.5 |
| Purchase of Fixed Assets | |||
| Purchase / Acquisition of Intangibles | |||
| Other Investing Cash Flow Items | -172 | -4.8 | 98.6 |
| Acquisition of Business | |||
| Other Investing Cash Flow | |||
| Cash from Investing Activities | -209 | -58.6 | 52.2 |
| Financing Cash Flow Items | -111 | -89.5 | -9.02 |
| Other Financing Cash Flow | |||
| Net Issuance / Retirement of Stock | |||
| Net Issuance / Retirement of Debt | |||
| Cash from Financing Activities | 53.4 | 47 | -168 |
| Beginning Cash Balance | |||
| Ending Cash Balance | |||
| Net Change in Cash | -40.9 | 117 | 52.2 |